Is There Any End in Sight to the Abbott Baby Formula Controversy?
23 Junho 2022 - 09:24AM
TipRanks
The baby formula controversy at Abbott Laboratories (ABT) got
exacerbated yet again after the Food and Drug Administration (FDA)
revealed that it had initiated an investigation linked to the death
of another infant who was given formula made by Abbott. The infant,
who died in January, was found with Cronobacter bacteria. However,
the FDA was notified about the mishap on June 10. Furthermore, four
babies who were reported ill after receiving Abbott formula also
had cronobacter infections. Turn of Events In February 2022,
Abbott recalled formula, including Similac, after four babies
became ill following the consumption of its products, of which two
infants died.
https://www.tipranks.com/news/is-there-any-end-in-sight-to-the-abbott-baby-formula-controversy?utm_source=advfn.com&utm_medium=referral
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Jul 2022 até Ago 2022
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Ago 2021 até Ago 2022